Immune checkpoint therapy—current perspectives and future directions

P Sharma, S Goswami, D Raychaudhuri, BA Siddiqui… - Cell, 2023 - cell.com
Immune checkpoint therapy (ICT) has dramatically altered clinical outcomes for cancer
patients and conferred durable clinical benefits, including cure in a subset of patients …

Signal pathways of melanoma and targeted therapy

W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …

Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

X Chen, M Firulyova, M Manis, J Herz, I Smirnov… - Nature, 2023 - nature.com
Extracellular deposition of amyloid-β as neuritic plaques and intracellular accumulation of
hyperphosphorylated, aggregated tau as neurofibrillary tangles are two of the characteristic …

An aged immune system drives senescence and ageing of solid organs

MJ Yousefzadeh, RR Flores, YI Zhu, ZC Schmiechen… - Nature, 2021 - nature.com
Ageing of the immune system, or immunosenescence, contributes to the morbidity and
mortality of the elderly,. To define the contribution of immune system ageing to organism …

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

S Jhunjhunwala, C Hammer, L Delamarre - Nature Reviews Cancer, 2021 - nature.com
Immune checkpoint blockade, which blocks inhibitory signals of T cell activation, has shown
tremendous success in treating cancer, although success still remains limited to a fraction of …

Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer

Y Chen, S Yang, J Tavormina, D Tampe, M Zeisberg… - Cancer cell, 2022 - cell.com
In contrast to normal type I collagen (Col1) heterotrimer (α1/α2/α1) produced by fibroblasts,
pancreatic cancer cells specifically produce unique Col1 homotrimer (α1/α1/α1). Col1 …

Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine …

S Zhao, L Wang, W Ding, B Ye, C Cheng… - Frontiers in …, 2023 - frontiersin.org
Background Bladder cancer (BLCA) is the most common malignancy of the urinary tract. On
the other hand, disulfidptosis, a mechanism of disulfide stress-induced cell death, is closely …

Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance

W Wu, JL Klockow, M Zhang, F Lafortune… - Pharmacological …, 2021 - Elsevier
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant,
primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …

Recent advances and discoveries in the mechanisms and functions of CAR T cells

RC Larson, MV Maus - Nature Reviews Cancer, 2021 - nature.com
This Review discusses the major advances and changes made over the past 3 years to our
understanding of chimeric antigen receptor (CAR) T cell efficacy and safety. Recently, the …

PD-1/PD-L1 checkpoint inhibitors in tumor immunotherapy

J Liu, Z Chen, Y Li, W Zhao, JB Wu… - Frontiers in …, 2021 - frontiersin.org
Programmed death protein 1 (PD1) is a common immunosuppressive member on the
surface of T cells and plays an imperative part in downregulating the immune system and …